Assess whether a prescription legitimately explains the positive (fde2a4)

Situation

DOT program-design consultant in a DOT-covered motor carrier after a fatal crash has one working extract — return-to-duty follow-up testing calendar — after an oral-fluid device the lab has not validated for this cutoff. DOT program-design consultant in a DOT-covered motor carrier after a fatal crash has return-to-duty follow-up testing calendar after an oral-fluid device the lab has not validated for this cutoff. If that extract cannot support a prescription legitimately explains, the honest Forensic Drug Testing Program Design and Audit output is hold.

Decision

DOT program-design consultant in a DOT-covered motor carrier after a fatal crash must choose Accept the result / Reject on custody / Recollect / Hold using return-to-duty follow-up testing calendar after an oral-fluid device the lab has not validated for this cutoff.

Hypotheses to test

• DOT program-design consultant can defend Accept the result from return-to-duty follow-up testing calendar after an oral-fluid device the lab has not validated for this cutoff in a Forensic Drug Testing challenge.
• DOT program-design consultant cannot defend Accept the result from return-to-duty follow-up testing calendar; Reject on custody is what the extract actually supports after an oral-fluid device the lab has not validated for this cutoff.
• An oral-fluid device the lab has not validated for this cutoff never reached the population in return-to-duty follow-up testing calendar — reopen intake, do not close a prescription legitimately explains.
• Two facts in return-to-duty follow-up testing calendar after an oral-fluid device the lab has not validated for this cutoff conflict for DOT program-design consultant; hold this Program Design and Audit file.

Analysis required

• Test whether a broken seal, timing miss, or donor explanation changes a prescription legitimately explains.
• Confirm the kit ID in return-to-duty follow-up testing calendar matches the collection log.
• Check MRO notes and cutoffs against the protocol a DOT-covered motor carrier after a fatal crash claims to run.
• For this Forensic Drug Testing Program Design and Audit file, read return-to-duty follow-up testing calendar against an oral-fluid device the lab has not validated for this cutoff and write the one fact that would move a prescription legitimately explains for DOT program-design consultant.